Caricamento...
Revisiting the Correlate of Reduced HIV Infection Risk in the Rv144 Vaccine Trial
The RV144 vaccine trial is the only clinical study to have shown a modest but statistically significant decrease in HIV infection risk. RV144 and the subsequent studies identifying the level of V1V2-specific antibodies as a correlate of reduced infection risk are still controversial despite many pap...
Salvato in:
| Pubblicato in: | J Virol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6694814/ https://ncbi.nlm.nih.gov/pubmed/31189712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00629-19 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|